皇隆制药 (834298.OC)

+ 收藏

财务摘要(报告期)(皇隆制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
每股指标:
 每股收益 - 基本(元) 0.09-0.370.06-0.160.02
 每股收益 - 稀释(元) 0.09-0.370.06-0.160.02
 每股收益 - 期末股本摊薄(元) 0.09-0.370.06-0.160.02
 每股净资产BPS(元) 1.411.321.751.691.86
 每股经营活动产生的现金流量净额(元) 0.270.190.240.280.09
 每股营业收入(元) 1.914.022.054.201.61
关键比率:
 净资产收益率 - 摊薄(%) 6.53-27.823.58-9.511.00
 净资产收益率 - 加权(%) 6.75-24.423.64-9.001.00
 净资产收益率 - 平均(%) 6.75-24.423.64-9.041.00
 净资产收益率 - 扣除(%) 4.73-53.90-7.24-13.81-2.14
 总资产净利率 - 平均(%) 1.26-5.350.92-2.570.21
 总资产报酬率ROA(%) 2.32-3.552.10-0.071.40
 投入资本回报率ROIC(%) 3.45-4.792.75-0.241.62
 销售毛利率(%) 53.7751.0754.2756.8753.46
 销售净利率(%) 4.77-9.163.03-3.860.79
 资产负债率(%) 81.0181.3174.5174.8269.34
 资产周转率(倍) 0.260.580.300.670.27
 销售商品提供劳务收到的现金/营业收入(%) 106.87104.42103.02109.51108.04
 营业利润同比增长率(%) 41.62-170.76349.0348.14433.09
 营业收入同比增长率(%) -6.69-4.3727.142.61-18.72
 利润总额同比增长率(%) 41.96-148.91454.7243.47410.04
 归属母公司股东的净利润同比增长率(%) 47.30-128.80235.2940.70227.07
 扣非后归属母公司股东的净利润同比增长率(%) 152.68-205.40-217.7129.50-2.47
 总资产同比增长率(%) 8.245.3513.0113.292.12
 总负债同比增长率(%) 17.6814.4921.4524.42-1.67
 净资产同比增长率(%) -19.29-21.76-5.99-9.4713.85
利润表摘要:
 营业总收入(元) 188,147,518.20394,972,711.39201,646,230.22413,008,692.87158,601,250.54
 营业总成本(元) 179,505,864.60472,253,774.67215,811,706.93433,845,428.23164,307,512.83
 营业收入(元) 188,147,518.20394,972,711.39201,646,230.22413,008,692.87158,601,250.54
 营业利润(元) 9,965,380.49-37,839,029.717,036,467.68-13,975,336.991,567,023.30
 利润总额(元) 9,931,180.50-37,886,082.536,995,723.05-15,220,749.231,261,121.14
 净利润(元) 8,974,048.88-36,190,937.896,111,366.22-15,961,599.381,252,763.25
 归属母公司股东的净利润(元) 9,059,157.29-36,093,052.616,150,063.86-15,774,909.221,834,277.90
 非经常性损益(元) 2,496,701.8933,834,698.9918,608,191.337,122,325.015,755,527.56
 归属母公司股东的净利润扣除非经常性损益(元) 6,562,455.40-69,927,751.60-12,458,127.47-22,897,234.23-3,921,249.66
资产负债表摘要:
 流动资产(元) 297,987,020.14281,691,654.87301,968,174.67323,568,619.64287,925,578.99
 固定资产(元) 221,631,758.59231,759,023.16246,040,369.82256,972,866.67268,375,238.28
 长期股权投资(元) 357,311.35640,939.29644,099.50897,250.48967,993.13
 资产总计(元) 730,607,325.51694,162,365.15675,006,544.31658,928,323.24597,294,613.65
 流动负债(元) 580,281,911.42457,621,210.38458,807,892.67478,735,848.70269,602,586.56
 非流动负债(元) 11,606,471.91106,796,261.4744,151,454.2314,256,643.35144,541,833.27
 负债合计(元) 591,888,383.33564,417,471.85502,959,346.90492,992,492.05414,144,419.83
 股东权益(元) 138,718,942.18129,744,893.30172,047,197.41165,935,831.19183,150,193.82
 归属母公司股东的权益(元) 138,804,637.62129,745,480.33171,988,596.80165,838,532.94182,947,040.97
 资本公积(元) 104,425,961.17104,425,961.17104,425,961.17104,425,961.17103,925,282.08
 盈余公积(元) 25,711,987.5725,711,987.5725,711,987.5725,711,987.5724,406,451.08
 未分配利润(元) -89,693,311.12-98,752,468.41-56,509,351.94-62,659,415.80-43,744,692.19
现金流量表摘要:
 销售商品提供劳务收到的现金(元) 201,080,312.43412,445,088.24207,738,250.10452,281,158.10171,350,896.33
 经营活动产生的现金净流量(元) 26,624,292.6318,997,332.2623,914,567.1127,345,458.819,180,575.31
 购建固定无形长期资产支付的现金(元) 38,702,617.57119,153,130.4260,608,577.4966,776,702.7418,593,158.43
 投资支付的现金(元) ---1,780,000.001,750,000.00
 投资活动产生的现金净流量(元) -38,693,117.57-118,275,081.07-59,867,528.14-68,391,166.13-20,212,458.43
 取得借款收到的现金(元) 69,750,000.00432,900,000.00115,000,000.00393,000,000.00122,000,000.00
 筹资活动产生的现金净流量(元) 11,238,361.0074,450,181.2911,536,701.6335,897,927.2514,757,052.92
 现金及现金等价物净增加(元) -830,463.94-24,827,567.31-24,416,259.40-5,147,779.553,725,169.80
 期末现金及现金等价物余额(元) 64,127,209.7464,957,673.6865,641,362.2689,785,240.9998,658,190.34
 折旧与摊销(元) 14,509,287.9438,588,402.3918,886,374.9837,798,895.6118,918,688.71
公告日期 2024-08-282024-04-302023-08-252023-04-282022-08-24
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院